TapewireFind a company

person · Reporting owner

ANDERSON KERRII B

Disclosed activity across 4 companies

Tapewire entity
22515
SEC CIK
0001227159

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ABERCROMBIE & FITCH CO /DE/ANF · Entity 3771DirectorAugust 03, 2026August 04, 2026
LABCORP HOLDINGS INC.LH · Entity 1277DirectorAugust 17, 2026August 18, 2026
SHERWIN WILLIAMS COSHW · Entity 2948DirectorOctober 02, 2026October 06, 2026
WORTHINGTON ENTERPRISES, INC.WOR · Entity 4282DirectorSeptember 23, 2025September 25, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ABERCROMBIE & FITCH CO /DE/

Report date August 03, 2026 · Filed August 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect4,220.522 Reported balance After 2026-08-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-08-03 · Grant · Acquired 91.044 · Balance 4,220.522

F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

LABCORP HOLDINGS INC.

Report date August 17, 2026 · Filed August 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,563 Reported balance After 2026-08-17 transaction · row 1
1 source row

Row 1 · 2026-08-17 · Sale · Disposed 3,000 · Balance 6,563

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Common StockSEC Table I · non-derivativeIndirectBy Alexa M. Anderson Separate Trust144 Reported balance Holding disclosure · report date 2026-08-17 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 144

Common StockSEC Table I · non-derivativeIndirectBy Cameron Taff Anderson Separate Trust144 Reported balance Holding disclosure · report date 2026-08-17 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 144

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SHERWIN WILLIAMS CO

Report date October 02, 2026 · Filed October 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectDeferred Fee Plan1,109.95 Reported balance After 2026-10-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-10-02 · Grant · Acquired 30.85 · Balance 1,109.95

F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Common StockSEC Table I · non-derivativeDirect5,819 Reported balance Holding disclosure · report date 2026-10-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 5,819

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

WORTHINGTON ENTERPRISES, INC.

Report date September 23, 2025 · Filed September 25, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect76,659 Reported balance After 2026-09-24 transaction · row 1
1 source row

Row 1 · 2026-09-24 · Grant · Acquired 2,510 · Balance 76,659

F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

Phantom StockSEC Table II · derivative / convertible securityDirect12,822.05 Reported balance After 2026-09-23 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-23 · Grant · Acquired 192.63 · Balance 12,822.05

F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.

Common SharesSEC Table I · non-derivativeIndirectBy Cameron Taff Anderson Separate Trust1,421 Reported balance Holding disclosure · report date 2025-09-23 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,421

Common SharesSEC Table I · non-derivativeIndirectBy Alexa M. Anderson Separate Trust1,421 Reported balance Holding disclosure · report date 2025-09-23 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 1,421

Common SharesSEC Table I · non-derivativeIndirectBy spouse436 Reported balance Holding disclosure · report date 2025-09-23 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 436

Filing footnotes · ownership attribution and instrument terms

F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2021 Filed Oct 4, 2021 14:50 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 439 $54.07 $23,736.73
Disclosure

SEC source: 0001209191-21-058739 · doc4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,879

Underlying: Common Shares · 439 shares

Expires not disclosed

F1 · derivative.exercise_price: The theoretical common shares (phantom stock) credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "2005 Director Deferred Compensation Plan") track Common Shares of Worthington Industries, Inc. (the "Company") on a one-for-one basis.

F2 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to theoretical common shares could be immediately transferred to other investment options under the terms of the deferred compensation plan in which the reporting person participates. See Note (3).

F3 · derivative.exercise_date: The 2005 Director Deferred Compensation Plan provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the 2005 Director Deferred Compensation Plan until distribution from the 2005 Director Deferred Compensation Plan. Distributions are made only in Common Shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F3 · derivative.expiration_date: The 2005 Director Deferred Compensation Plan provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the 2005 Director Deferred Compensation Plan until distribution from the 2005 Director Deferred Compensation Plan. Distributions are made only in Common Shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F4 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to dividend reinvestment under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed September 28, 2020.

Read SEC document
September 29, 2021 Filed Sep 30, 2021 20:46 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 2,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-058196 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,457

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date (September 29, 2022); or (2) the date on which the next Annual Meeting of Shareholders of Worthington Industries, Inc. is held.

Read SEC document
September 03, 2021 Filed Oct 14, 2021 18:22 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GiftCommon Shares 1,421 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060454 · doc4.xml · nonDerivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Alexa M. Anderson Separate Trust

Disclosed balance after: 1,421

F2 · shares: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · balance_after: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
September 03, 2021 Filed Oct 14, 2021 18:22 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GiftCommon Shares 1,421 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060454 · doc4.xml · nonDerivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Cameron Taff Anderson Separate Trust

Disclosed balance after: 1,421

F2 · shares: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · balance_after: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
September 03, 2021 Filed Oct 14, 2021 18:22 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GiftCommon Shares 2,842 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060454 · doc4.xml · nonDerivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 0

F2 · shares: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F1 · balance_after: On September 2, 2021, the reporting person (in her capacity as trustee of the grantor retained annuity trust) distributed 2,258 Common Shares from the grantor retained annuity trust (which had previously been reported as owned indirectly) to her individual brokerage account whereby these Common Shares are reported as owned directly.

F2 · balance_after: This transaction involved distributions, on September 3, 2021, of an aggregate of 2,842 Common Shares by the reporting person (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (1,421 Common Shares being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these Common Shares, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
September 02, 2021 Filed Sep 2, 2021 21:25 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 PurchaseClass A Common Stock 1,000 $35.17 $35,173.00
Disclosure

SEC source: 0001225208-21-011974 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,602

F1 · price: Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $35.05 to $35.19. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 18:23 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 194 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-011046 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,763

Underlying: Class A Common Stock · 194 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 17:48 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 33.64 $274.96 $9,249.65
Disclosure

SEC source: 0001209191-21-045763 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 367.44

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantRestricted Stock Unit · Derivative 3,615 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-009308 · doc4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,615

Underlying: Class A Common Stock · 3,615 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
May 20, 2021 Filed Jun 11, 2021 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionRestricted Stock Unit · Derivative 13,205 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-009308 · doc4.xml · derivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 13,205 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
May 20, 2021 Filed Jun 11, 2021 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionClass A Common Stock 13,205 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-009308 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 12:57 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 195 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007545 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,569

Underlying: Class A Common Stock · 195 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 20:50 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 35.26 $253.36 $8,933.47
Disclosure

SEC source: 0001209191-21-025892 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 333.15

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 22:27 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 221 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-011974 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 970

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 653 are restricted stock units.

Read SEC document
February 04, 2021 Filed Feb 8, 2021 19:53 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 986 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-004326 · form4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 771

Underlying: Common Stock · 986 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 4, 2021.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 4, 2021.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 04, 2021 Filed Feb 8, 2021 19:53 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 986 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-004326 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Read SEC document
February 02, 2021 Filed Feb 4, 2021 18:09 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 771 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-003915 · form4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,757

Underlying: Common Stock · 771 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 01, 2021 Filed Feb 2, 2021 23:29 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 127 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-001467 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,374

Underlying: Class A Common Stock · 127 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 16:05 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 10.73 $727.84 $7,809.72
Disclosure

SEC source: 0001209191-21-003175 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 99.07

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
December 03, 2020 Filed Feb 4, 2021 18:09 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GiftCommon Stock 746 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-003915 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,894

F1 · balance_after: Amount reflects annuity payment of 480 shares made by the reporting person's grantor retained annuity trust to the reporting person on September 23, 2020.

Read SEC document
November 02, 2020 Filed Nov 3, 2020 21:13 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 207 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-012956 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

Underlying: Class A Common Stock · 207 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 17:59 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 11.34 $688.84 $7,811.45
Disclosure

SEC source: 0001209191-20-053976 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 88.17

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
September 25, 2020 Filed Sep 28, 2020 20:32 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 602 $39.47 $23,760.94
Disclosure

SEC source: 0001209191-20-052209 · doc4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,287

Underlying: Common Shares · 602 shares

Expires not disclosed

F2 · derivative.exercise_price: The theoretical common shares (phantom stock) credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "2005 Director Deferred Compensation Plan") track Common Shares of Worthington Industries, Inc. (the "Company") on a one-for-one basis.

F3 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to theoretical common shares could be immediately transferred to other investment options under the terms of the deferred compensation plan in which the reporting person participates. See Note (4).

F4 · derivative.exercise_date: The 2005 Director Deferred Compensation Plan provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the 2005 Director Deferred Compensation Plan until distribution from the 2005 Director Deferred Compensation Plan. Distributions are made only in Common Shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F4 · derivative.expiration_date: The 2005 Director Deferred Compensation Plan provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the 2005 Director Deferred Compensation Plan until distribution from the 2005 Director Deferred Compensation Plan. Distributions are made only in Common Shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F5 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to dividend reinvestment under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed September 27, 2019.

Read SEC document
September 23, 2020 Filed Sep 24, 2020 19:51 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 3,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-051868 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,507

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date (September 23, 2021); or (2) the date on which the next Annual Meeting of Shareholders of Worthington Industries, Inc. is held.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:31 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 215 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010294 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,040

Underlying: Class A Common Stock · 215 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:10 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 13.28 $588.25 $7,811.96
Disclosure

SEC source: 0001209191-20-041738 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 76.68

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:28 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionRestricted Stock Unit · Derivative 9,849 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-008151 · doc4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 9,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:28 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantRestricted Stock Unit · Derivative 13,205 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-008151 · doc4.xml · derivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,205

Underlying: Class A Common Stock · 13,205 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:28 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionClass A Common Stock 9,849 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-008151 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,397

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2020 Filed May 6, 2020 22:30 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007201 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 825

Underlying: Class A Common Stock · 259 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 12:02 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 18.19 $429.42 $7,811.15
Disclosure

SEC source: 0001209191-20-023697 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 63.25

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
March 12, 2020 Filed Mar 13, 2020 17:01 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 PurchaseClass A Common Stock 2,000 $10.17 $20,339.60
Disclosure

SEC source: 0001225208-20-004996 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,548

Read SEC document
February 18, 2020 Filed Feb 20, 2020 15:45 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010922 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 749

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 649 are restricted stock units.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 20:36 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 1,227 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-005597 · form4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 986

Underlying: Common Stock · 1,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2020.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2020.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 20:36 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 1,227 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-005597 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,160

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Read SEC document
February 04, 2020 Filed Feb 6, 2020 19:46 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 986 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-003956 · form4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,213

Underlying: Common Stock · 986 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 4, 2021.

F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 4, 2021.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 19:15 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 160 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-001678 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554

Underlying: Class A Common Stock · 160 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:50 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 13.76 $567.91 $7,814.44
Disclosure

SEC source: 0001209191-20-002232 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 44.93

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
November 03, 2019 Filed Nov 5, 2019 22:00 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 154 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014156 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389

Underlying: Class A Common Stock · 154 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
October 04, 2019 Filed Oct 8, 2019 20:45 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 14.23 $549.10 $7,813.69
Disclosure

SEC source: 0001209191-19-052769 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 31.11

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
September 26, 2019 Filed Sep 27, 2019 18:14 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 676 $35.14 $23,754.64
Disclosure

SEC source: 0001209191-19-050951 · doc4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,529

Underlying: Common Shares · 676 shares

Expires not disclosed

F4 · derivative.exercise_price: The theoretical common shares (phantom stock) credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "2005 Director Deferred Compensation Plan") track Common Shares of Worthington Industries, Inc. (the "Company") on a one-for-one basis.

F5 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to theoretical common shares could be immediately transferred to other investment options under the terms of the deferred compensation plan in which the reporting person participates. See note (6).

F6 · derivative.exercise_date: The Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan"), provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in common shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F6 · derivative.expiration_date: The Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan"), provides that effective October 1, 2014 and thereafter any amount credited in a participant's account to the phantom stock fund (i.e. theoretical common shares deemed investment option) may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in common shares of Worthington Industries, Inc. and generally commence upon the leaving the Board of Directors of Worthington Industries, Inc.

F7 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the Plan since the date on which the amount of theoretical common shares credited pursuant to dividend reinvestment under the Plan was last updated in the reporting person's Form 4 filed October 1, 2018.

Read SEC document
September 25, 2019 Filed Sep 27, 2019 18:14 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 3,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-050951 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,007

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date (September 25, 2020); or (2) the date on which the next Annual Meeting of Shareholders of Worthington Industries, Inc. is held.

F2 · balance_after: Excludes 8,650 Common Shares previously owned directly which were contributed to a grantor retained annuity trust on August 27, 2019.

Read SEC document
September 23, 2019 Filed Sep 25, 2019 17:40 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionNon-qualified Stock Options · Derivative 2,600 $0.00 Strike: $98.49 $0.00
Disclosure

SEC source: 0001127602-19-029077 · form4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,600 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F4 · derivative.exercise_date: The options vested in three equal annual installments beginning on the date reflected in this column and are now fully exercisable.

Read SEC document
September 23, 2019 Filed Sep 25, 2019 17:40 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 2,600 $171.85 $446,810.00
Disclosure

SEC source: 0001127602-19-029077 · form4.xml · nonDerivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,933

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
September 23, 2019 Filed Sep 25, 2019 17:40 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 2,600 $98.49 $256,074.00
Disclosure

SEC source: 0001127602-19-029077 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2 · balance_after: On August 27, 2019, the reporting person contributed 1,200 shares of common stock to a grantor retained annuity trust for the benefit of certain of her family members and for which the reporting person is the annuitant. The reporting person is the trustee of the trust.

Read SEC document
August 05, 2019 Filed Aug 7, 2019 20:42 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 149 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010992 · doc4.xml · derivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232

Underlying: Class A Common Stock · 149 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
July 05, 2019 Filed Jul 9, 2019 22:25 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 16.84 $463.88 $7,811.74
Disclosure

SEC source: 0001209191-19-041626 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 16.84

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 19:26 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionNon-qualified Stock Options · Derivative 3,100 $0.00 Strike: $77.19 $0.00
Disclosure

SEC source: 0001127602-19-022529 · form4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,100 shares

Expires 2020-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 19:26 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 3,100 $170.00 $527,000.00
Disclosure

SEC source: 0001127602-19-022529 · form4.xml · nonDerivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,133

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 19:26 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 3,100 $77.19 $239,289.00
Disclosure

SEC source: 0001127602-19-022529 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.